Report cover image

Oncology Based Molecular Diagnostics Market Growth, Size, Trends Analysis- By Type, By Product, By Technology - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 10, 2025
Length 210 Pages
SKU # SPER20337442

Description

Oncology Based Molecular Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Oncology Based Molecular Diagnostics Market Size- By Component, By Industry – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Oncology Based Molecular Diagnostics Market is predicted to reach 12.47 billion by 2034 with a CAGR 12.36%.

Oncology-based molecular diagnostics is a specialized area of medical testing that utilizes molecular biology techniques to identify genetic, epigenetic, and proteomic changes linked to cancer. These tests are instrumental in detecting specific mutations, gene expression patterns, or biomarkers within cancer cells, which are essential for accurate diagnosis, prognosis, and selecting appropriate treatments.

Restraints:The oncology-based molecular diagnostics market encounters several significant challenges. A primary obstacle is the high cost of advanced diagnostic technologies, which can restrict access, especially in low- and middle-income countries. The complex nature of cancer biology and tumor heterogeneity also makes it challenging to create molecular tests that are universally effective.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Type, By Product, By Technology

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
Abbott, Bayer AG, BD, Cepheid, Agilent Technologies, Inc., Danaher, Hologic, Inc., Qiagen, F. Hoffmann-La Roche Ltd., Siemens.

Global Oncology Based Molecular Diagnostics Market Segmentation:


By Type: Based on the Type, Global Oncology Based Molecular Diagnostics Market is segmented as; Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer.

By Product: Based on the Product, Global Oncology Based Molecular Diagnostics Market is segmented as; Instruments, Reagents, Others

By Technology: Based on the Technology, Global Oncology Based Molecular Diagnostics Market is segmented as; PCR, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, Sequencing, TMA, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

210 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Oncology Based Molecular Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Oncology Based Molecular Diagnostics Market
7. Global Oncology Based Molecular Diagnostics Market, By Type, (USD Million) 2021-2034
7.1. Breast Cancer
7.2. Prostate Cancer
7.3. Colorectal Cancer
7.4. Cervical Cancer
7.5. Liver Cancer
7.6. Lung Cancer
7.7. Blood Cancer
7.8. Kidney Cancer
7.9. Other Cancer
8. Global Oncology Based Molecular Diagnostics Market, By Product, (USD Million) 2021-2034
8.1. Instruments
8.2. Reagents
8.3. Others
9. Global Oncology Based Molecular Diagnostics Market, By Technology, (USD Million) 2021-2034
9.1. PCR
9.2. In Situ Hybridization
9.3. INAAT
9.4. Chips and Microarrays
9.5. Mass Spectrometry
9.6. Sequencing
9.7. TMA
9.8. Others
10. Global Oncology Based Molecular Diagnostics Market, (USD Million) 2021-2034
10.1. Global Oncology Based Molecular Diagnostics Market Size and Market Share
11. Global Oncology Based Molecular Diagnostics Market, By Region, 2021-2034 (USD Million)
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Bayer AG
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. BD
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Cepheid
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Agilent Technologies, Inc.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Danaher
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Hologic, Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Qiagen
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. F. Hoffmann-La Roche Ltd.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Siemens
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us